From Raw Data to Reliable Results. In Clicks, Not Code
Validated nf-core pipelines from raw sequencing data to reproducible insights. Automated for reliability, with Notebooks for deeper exploration.
Pan.bio is an AI-powered, end-to-end genomics platform built for every scientist, and every population the world has too often left behind.
Our Mission
Empowering scientists to transform genomic data into global breakthroughs via an end-to-end, AI-powered platform that bridges the distance between raw sequences and world-changing insights.
Our focus on underrepresented populations isn't a marketing line, it's the reason we exist. From MENA breast cancer research to Pan-Arab diabetes cohorts, we build the infrastructure that lets clinicians, researchers, and pharma teams generate the genomic insights their populations have been missing from for decades.
Building the genomic era,
one population at a time.
Our vision is to become the universal operating system for the genomic era, providing the intelligent, privacy-first infrastructure that democratizes discovery while spearheading original research to translate the world's biological data into the cures of tomorrow.
We aim to be both the engine that powers global genomic research and an active participant in driving discovery ourselves, contributing directly to the scientific community through our own R&D.
How We Build
Genomic research shouldn't be reserved for teams with the most engineers. We build for the scientist, not the stack.
Privacy and regulatory safety aren't afterthoughts. They're enforced at the infrastructure level, built into every line of code.
We tell you what's live, what's in development, and what we're not building yet. No overclaiming.
Every product decision asks: who does this leave out? MENA, South Asia, and historically underserved populations are the starting point, not an afterthought.
We don't just build tools for discovery. We participate in it, contributing to peer-reviewed research and open science initiatives alongside the global genomics community.
Our Reach
Trusted by scientists from leading research labs, hospitals, and clinical institutions worldwide.
Trusted Partners
Platform
From raw sequencing data to clinical reports to cohort discovery, Pan.bio brings the entire genomic workflow into a single AI-powered platform; so teams stop stitching tools together and start delivering results.
Validated nf-core pipelines from raw sequencing data to reproducible insights. Automated for reliability, with Notebooks for deeper exploration.
A pre-configured notebook environment where BioMind generates code, debugs errors, and helps turn one-off discoveries into reusable team workflows.
Guideline-aware clinical variant classification powered by ACMG/AMP, CanVIG, ACGS, and ClinGen. AI-assisted, human-controlled.
Connecting hospitals and labs with pharma and biotech researchers. Unlock underrepresented populations while keeping data under provider ownership at every step.
Research & Publications
Pan.bio isn't only a platform. We're active participants in genomic research, contributing to peer-reviewed studies, open-science initiatives, and collaborative spotlights with leading researchers across the global genomics community.
Read our blogPan.bio Research Team · March 15, 2026
Enforced at the infrastructure level, your data stays in your jurisdiction, always.
Whether you're running your first pipeline, interpreting a clinical variant, or partnering with us on research, Pan.bio is built to meet you where you are.
No credit card required · Start in minutes